Skip to main content
Enterprise AI Analysis: Is it really keratoconus or pseudo-keratoconus? – Topographic mimicry

Enterprise AI Analysis

Is it really keratoconus or pseudo-keratoconus? – Topographic mimicry

This case series aimed to present eyes with a topographic pseudo-keratoconus configuration resulting from corneal diseases other than keratoconus (KC). It highlights that different corneal pathologies can imitate a topographic KC configuration. Differentiating pseudo-keratoconus from true ectasia is clinically relevant to avoid inappropriate treatment and ensure correct patient counseling, requiring careful slit-lamp examination and advanced diagnostics.

Executive Impact Summary

This study highlights the critical need for advanced diagnostic protocols in ophthalmology, particularly when distinguishing between true keratoconus and various corneal pathologies that mimic its topographic presentation. Misdiagnosis can lead to unnecessary, costly, and potentially harmful interventions, impacting patient outcomes and healthcare resource allocation.

0 Total Eyes Studied
0 Total Patients
0 Mean Kmax
0 Mean TKC Stage
0 Mean I-S Value
0 Mean Thinnest Corneal Thickness
0 Female Patients
0 Male Patients

Deep Analysis & Enterprise Applications

Select a topic to dive deeper, then explore the specific findings from the research, rebuilt as interactive, enterprise-focused modules.

What is known

  • Keratoconus is a bilateral, quasi-inflammatory progressive ectatic corneal disease with paracentral thinning, which, if overlooked, may lead to visual impairment.
  • A diagnosis of keratoconus can be made using slit-lamp examination, Scheimpflug tomography, and analysis of corneal biomechanics.

What is new

  • There are many corneal disease entities, that can mimic keratoconus topographically, showing ectasia and paracentral, inferior-temporal thinning.
  • Most eyes with a pseudokeratoconic pattern in this study presented with a corneal scar or Map-Dot-Fingerprint dystrophy.

Keratoconus (KC) is a bilateral, quasi-inflammatory progressive ectatic corneal disease with paracentral thinning. Its cause is not fully understood, but genetic predispositions and exogenous factors like eye rubbing play a role. KC can lead to progressive irregular astigmatism, scarring, and visual impairment. Therapeutic options range from contact lenses to surgical interventions. Early diagnosis is crucial but challenging with slit-lamp alone, requiring computer-based tomography and biomechanical analysis. Differentiating pseudo-keratoconus from true ectasia is critical to avoid unnecessary treatments and ensure proper patient counseling. This study aims to present cases with topographic KC configuration but no actual KC, leading to a 'pseudo-keratoconus' diagnosis.

The study was conducted at the Homburg Keratoconus Center, which tracks over 3,400 KC patients. KC diagnosis requires abnormal posterior elevation, corneal thickness distribution, non-inflammatory thinning, and tomography (Scheimpflug or OCT), with Kmax > 47.0 dpt as a helpful parameter. Inclusion criteria for this study included corneas classified as KC by Scheimpflug imaging (TKC) and a typical elevation data profile with irregular astigmatism and inferior-superior asymmetry (I-S value > 1.4 at 6 mm). Differentiation relied on patient history, slit-lamp findings, and corneal thickness. Scheimpflug tomography (Pentacam®) and corneal biomechanics (Corvis® ST, measuring CBI, TBI, E-staging) were analyzed. Biomechanics were not universally performed but supported morphological interpretation qualitatively. Data were reported as mean±standard deviation or median [range], and categorical data as n/N (%).

Fifty-seven eyes from 37 patients (mean age 49, 16 female:21 male) were included. Mean BCVA was 20/40. Key corneal parameters included mean Kmax 50 D, mean TKC 2, mean I-S value 2.87, and mean thinnest corneal thickness 528 µm. Study eyes were categorized into three groups based on the cause of topographic changes: (1) inferior steepening (35 eyes, e.g., corneal scar (17), Map-Dot-Fingerprint dystrophy (10), FECD (5)); (2) superior steepening (19 eyes, e.g., Map-Dot-Fingerprint dystrophy (7), irregular astigmatism (4), DED (4)); and (3) post-phototherapeutic keratectomy (3 eyes). Corneal biomechanics, when available (11/57 eyes), showed deformation amplitudes (1.05 to 1.27 mm) consistent with stiffened corneas rather than true ectasia.

KC diagnosis relies on Scheimpflug tomography and corneal biomechanics, but a thorough patient history and slit-lamp examination are essential. Pseudokeratoconus must be considered if no obvious KC signs are present on slit lamp despite a KC topographic configuration. This study, with 57 eyes, identified various pathologies mimicking KC: corneal scar (19 eyes), Map-Dot-Fingerprint dystrophy (17), FECD (5), irregular astigmatism (4), DED (4), Salzmann nodular degeneration (3), post-PTK (3), and vortex keratopathy (2). Corneal scarring from infections or trauma, epithelial basement membrane dystrophy (e.g., Map-Dot-Fingerprint), Fuchs endothelial corneal dystrophy with edema, and Salzmann nodular degeneration can all cause KC-like topography. Post-PTK changes, DED, and vortex keratopathy can also mimic KC. Proper alignment during imaging is crucial to avoid artifacts. AS-OCT and AI are emerging tools to refine differential diagnosis. Recommendations include careful slit-lamp inspection, repeat imaging, using epithelial mapping/AS-OCT, and deferring KC-specific interventions until true ectasia is verified.

Enterprise Process Flow: Corneal Pathologies Mimicking Keratoconus

Corneal Scar
Map-Dot-Fingerprint Dystrophy
Fuchs Endothelial Corneal Dystrophy (FECD)
Irregular Astigmatism without other pathology
Dry Eye Disease (DED)
Salzmann Nodular Degeneration
Post-Phototherapeutic Keratectomy (PTK)
Vortex Keratopathy
0 of pseudo-KC cases linked to Corneal Scar or Map-Dot-Fingerprint Dystrophy

Key Differentiators: True vs. Pseudo-Keratoconus

Feature True Keratoconus Pseudo-Keratoconus
Slit-Lamp Examination Vogt's striae, Fleischer's ring, paracentral stromal thinning Scars, dystrophies (e.g., fingerprints, guttae), nodules, edema
Scheimpflug Tomography Abnormal posterior elevation, progressive thinning, specific biomechanical indices (e.g., TBI) KC-like topography but often stable, varying thickness profiles, specific biomechanical indices (e.g., CBI) indicating stiffening (if available)
Corneal Biomechanics Softening (e.g., high CBI/TBI, high deformation amplitude) Often normal or stiffened (e.g., low CBI/TBI, low deformation amplitude)
Treatment Implications Cross-linking, ICRS, keratoplasty Treat underlying pathology (e.g., PTK for dystrophy, DMEK for FECD), refractive correction (glasses/CLs)
Patient Counseling Disease progression, long-term management Management of underlying condition, reassurance about stability (if applicable)

Real-World Examples of Topographic Mimicry

Case 1: Corneal Scarring Post-Trauma

A 38-year-old male presented with suspected KC and reduced visual acuity following a car accident 20 years prior. Tomography showed inferior corneal steepening (Kmax 54.8 D OD, 53.2 D OS), TKC stage 2, and I-S values of 2 and 2.46. However, slit-lamp examination revealed visible inferiorly located corneal scarring. Diagnosis was corneal scarring with highly irregular astigmatism, not KC.

Case 2: Map-Dot-Fingerprint Dystrophy

A 64-year-old female presented with suspected KC due to fluctuating visual acuity. Tomography showed inferior corneal steepening (Kmax 48.1 D OD, 48.6 D OS) and TKC values of "KC possible" and 1. A detailed slit-lamp examination in retroillumination revealed superficial grey shapes and fingerprints. Diagnosis was Map-Dot-Fingerprint dystrophy, treated with phototherapeutic keratectomy.

Case 3: Fuchs Endothelial Corneal Dystrophy (FECD)

A 44-year-old male presented with suspected corneal edema after acute hydrops and reduced visual acuity. Tomography showed inferior corneal steepening (Kmax 48.5 D OD, 65.8 D OS) and TKC values of 1-2 and 3-4. Slit-lamp examination, however, revealed guttae, corneal edema, and Descemet's membrane folds. Diagnosis was FECD, leading to Descemet Membrane Endothelial Keratoplasty (DMEK).

Calculate Your Potential AI Impact

Estimate the efficiency gains and cost savings for your enterprise by implementing intelligent automation strategies, informed by insights like those from this analysis.

Estimated Annual Savings $0
Annual Hours Reclaimed 0

Your AI Implementation Roadmap

A phased approach ensures successful integration and measurable ROI for complex AI initiatives in ophthalmology and beyond.

Phase 01: Discovery & Strategy

Conduct a comprehensive audit of existing diagnostic workflows, identify critical pain points in patient evaluation (e.g., differentiating complex corneal conditions), and define clear objectives for AI integration. Develop a strategic roadmap tailored to your specific clinical needs and resource availability.

Phase 02: Data Preparation & Model Training

Curate and preprocess large datasets of corneal images (Scheimpflug, OCT), clinical notes, and patient outcomes. Train and validate AI models for tasks such as automated topographic analysis, pseudo-keratoconus detection, and differential diagnosis, ensuring robustness and accuracy.

Phase 03: Pilot Implementation & Validation

Deploy AI tools in a controlled pilot environment within your clinic. Integrate with existing EMR systems and diagnostic equipment. Collect feedback from ophthalmologists and technicians, rigorously validate AI performance against ground truth, and make necessary adjustments for optimal clinical utility.

Phase 04: Full-Scale Deployment & Monitoring

Roll out the AI solution across all relevant clinical departments. Establish continuous monitoring systems for model performance, data drift, and user adoption. Provide ongoing training and support to clinical staff, ensuring seamless integration into daily practice and maximizing long-term benefits.

Ready to Transform Your Enterprise?

Leverage cutting-edge AI insights to optimize your operations, enhance diagnostic precision, and drive innovation. Our experts are ready to guide you.

Ready to Get Started?

Book Your Free Consultation.

Let's Discuss Your AI Strategy!

Lets Discuss Your Needs


AI Consultation Booking